NPPM
BSX icon

North Point Portfolio Managers’s Boston Scientific BSX Stock Holding History

North Point Portfolio Managers’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.73M Sell
134,225
-13,102
-9% -$711K 0.95% 38
2026
Q1 		$9.24M Buy
147,327
+43,893
+42% +$3.51M 1.65% 33
2025
Q4 		$9.86M Buy
+103,434
New +$10.1M 1.67% 31

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

North Point Portfolio Managers's BSX Position: Q2 2026 in Review

North Point Portfolio Managers reduced its Boston Scientific (BSX) stake by 8.9% in Q2 2026, selling an estimated $711K and leaving 134,225 shares worth $5.73M. The position accounts for 0.95% of the portfolio, ranked #38.

North Point Portfolio Managers first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.86M in Q4 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • North Point Portfolio Managers held 134,225 shares of Boston Scientific worth $5.73M as of Q2 2026.
  • North Point Portfolio Managers sold 13,102 Boston Scientific shares in Q2 2026, an estimated $711K.
  • Boston Scientific made up 0.95% of North Point Portfolio Managers's portfolio in Q2 2026, its #38 holding.
  • North Point Portfolio Managers first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • North Point Portfolio Managers's Boston Scientific position peaked at $9.86M in Q4 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on North Point Portfolio Managers's 13F filing for Q2 2026, filed 31 Jul 2026.